glp 1 drugs and ms The GLP-1 revolution: What UAB researchers are discovering about how these work Episode 444: A GLP-1 Drug

Neuroscience 277, 613

Clinical trial averages: Wegovy (semaglutide): ~15% of body weight Zepbound (tirzepatide): ~20% of body weight Some people lose considerably more

the October 2024 Westminster Hall debate (Cat Smith MP) and PoTS UK Parliamentary Campaign 2025

however, our data show that BACH1 stabilization promotes angiogenesis, which may be attributed to cell type specificity or context-dependent downstream targets (e.g., PDGFR instead of HO-1) [17, 18]

Tirzepatide, another GLP-1 option, was not included because it became available after the study began

Quick Highlight: C rate indicates the discharge rate, but it is safe for the batteries